Sea You at Fetch Long Beach
|Articles|May 18, 2011

Today's Daily Dose: Piroxicam

Learn about the potential anticancer effects of piroxicam.

Untitled Document

“The potential anticancer effects of piroxicam in cats with transitional cell carcinoma have not been thoroughly described, but, anecdoctally, piroxicam appears to be well-tolerated at a dosage of 0.3 mg/kg by mouth two or three times a week. Using this dosing scheme in cats with transitional cell carcinoma should be safe based on prior pharmacokinetic studies of oral piroxicam conducted in healthy cats; however, its anticancer effectiveness remains poorly characterized in cancer-bearing cats.”

-Timothy M. Fan, DVM, PhD, DACVIM (internal medicine and oncology)

From Just Ask the Expert: Transitional cell carcinoma of the bladder and piroxicam

 

 


Related to this article

Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.
Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
Inside veterinary social work
In a slideshow drawn from an on-site dvm360 interview at the 2026 Fetch National Harbor Veterinary Conference, a veterinary oncologist and a veterinary social worker walk through how the role supports owners and staff across a pet's cancer diagnosis, treatment, and end-of-life care.